Stocksigma LogoStocksigma Logo

ANG Lifesciences India Approves Q2 Results and Appoints Additional Independent Director

ANG Lifesciences India Limited's Board approved the unaudited standalone and consolidated financial results along with the limited review report for the

ANG Lifesciences India Approves Q2 Results and Appoints Additional Independent Director

ANG Lifesciences India Ltd 路 Change in Management 路 15 Nov 2026, 3:04 am

ANG Lifesciences India Approves Q2 Results and Appoints Additional Independent Director ANG Lifesciences India Limited's Board approved the unaudited standalone and consolidated financial results along with the limited review report for the quarter and half-year ended 30th Sep'26. Additionally, the Board approved the appointment of Mrs. Preeti Sarin as an Additional Independent Director for a five-year term effective 14th Nov'26 to 13th Nov'31, subject to shareholder approval. Sarin holds a BBA degree with over a decade of administrative and operational experience and is unrelated to any existing board directors.

Original exchange filing (PDF)

More announcements from ANG Lifesciences India Ltd

All ANG Lifesciences India Ltd announcements